Over the past few days, I — along with many of my library colleagues — have received several email messages about a boycott of Elsevier by academics who in the past may have reviewed for, edited, or published in Elsevier journals and are now pledging not to do so again. An article in the Chronicle of Higher Education characterizes the boycott as “gather(ing) steam” and refers readers to a website
Welcome to the world of enterprise. But note that what you call bias is in availability, not in publication. My conjecture is that this availability advantage accrues to wealthy universities and authors as well. Are you suggesting that this particular advantage of wealth be restricted or regulated? For all wealthy sources, or just drug companies? Or are you merely pointing out that this is a side
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く